Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-25-058333
Filing Date
2025-04-25
Accepted
2025-04-25 07:47:08
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-25

Document Format Files

Seq Description Document Type Size
1 ARS tenx-10-k-2024-ars.pdf ARS 371130
  Complete submission text file 0000950170-25-058333.txt   512758
Mailing Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517
Business Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517 919-855-2100
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

EIN.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-34600 | Film No.: 25870010
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)